| Metric | Q3 2024 | Q2 2024 | Q3 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $3.3B | $4.1B | $3.3B | -18.1% | -0.1% |
| Op. Income | $129M | $220M | $144M | -41.6% | -10.4% |
| Gross Margin | 23.6% | 21.8% | 22.1% | 1.8pp | 1.5pp |
| Net Margin | 2.6% | 3.9% | 3.0% | -1.3pp | -0.4pp |
| EPS (Diluted) | $2.33 | $4.24 | $2.67 | -45.0% | -12.7% |
| Free Cash Flow | -$27M | $146M | $27M | -118.5% | -201.6% |
| Item | Amount |
|---|---|
| REVENUE | $3.3B |
| Cost of Revenue | $2.5B |
| GROSS PROFIT | $787M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $658M |
| Operating Expenses | $658M |
| Cost & Expenses | $3.2B |
| OPERATING INCOME | $129M |
| Interest Income | $0 |
| Interest Expense | $14M |
| Other Income/Expenses | -$14M |
| INCOME BEFORE TAX | $115M |
| Income Tax Expense | $28M |
| Net Income from Continuing Ops | $87M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $87M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $87M |
| D&A | $89M |
| EBIT | $129M |
| EBITDA | $218M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $3.3B |
| Cost of Revenue | $2.5B |
| GROSS PROFIT | $787M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $658M |
| Operating Expenses | $658M |
| Cost & Expenses | $3.2B |
| OPERATING INCOME | $129M |
| Interest Income | $0 |
| Interest Expense | $14M |
| Other Income/Expenses | -$14M |
| INCOME BEFORE TAX | $115M |
| Income Tax Expense | $28M |
| Net Income from Continuing Ops | $87M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $87M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $87M |
| D&A | $89M |
| EBIT | $129M |
| EBITDA | $218M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $87M |
| Depreciation & Amortization | $89M |
| Stock-Based Compensation | $10M |
| Deferred Income Tax | $9M |
| Other Non-Cash Items | $1M |
| Change in Working Capital | -$73M |
| OPERATING CASH FLOW | $123M |
| Capital Expenditure | -$150M |
| Acquisitions (Net) | -$157M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $12M |
| NET CASH FROM INVESTING | -$295M |
| Net Debt Issuance | -$13M |
| Common Stock Repurchased | -$30M |
| Common Dividends Paid | -$16M |
| Other Financing Activities | -$176.0K |
| NET CASH FROM FINANCING | -$60M |
| FREE CASH FLOW | -$27M |
| Net Change in Cash | -$232M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $178M |
| Short-Term Investments | $0 |
| Net Receivables | $158M |
| Inventory | $415M |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $781M |
| PP&E (Net) | $4.6B |
| Goodwill | $647M |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $198M |
| TOTAL NON-CURRENT ASSETS | $5.4B |
| TOTAL ASSETS | $6.2B |
| Account Payables | $522M |
| Short-Term Debt | $53M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $881M |
| Long-Term Debt | $1.6B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $592M |
| Other Non-Current Liabilities | $203M |
| TOTAL NON-CURRENT LIABILITIES | $2.4B |
| TOTAL LIABILITIES | $3.3B |
| Common Stock | $30M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $2.9B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.9B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.9B |
| TOTAL LIABILITIES & EQUITY | $6.2B |
| Total Debt | $1.6B |
| Net Debt | $1.5B |
